Orbital Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Orbital Therapeutics?

Orbital Therapeutics has 14 investors including Andreessen Horowitz And Invus.

Q: How much funding has Orbital Therapeutics raised to date?

Orbital Therapeutics has raised obfuscated.

Overview

Orbital Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Orbital Therapeutics

CB Rank

3062

Orbital Therapeutics is a biotechnology company that develops RNA-based medicines to treat disease in humans.

Acquired by

Bristol-Myers Squibb

Founded

obfuscation

Private

Series A

Cambridge, Massachusetts, United States

51-100

orbitaltx.com

Alternative Medicine

Biotechnology

Life Science

Therapeutics

Funding Rounds

Series A

OBF

obfuscation

Seed

OBF

obfuscation

Key People

Adam Raff: Senior Vice President, Clinical Development
Past Role: Montai Therapeutics, Head of Clinical Development
Gilles Besin: Chief Scientific Officer

Details

Legal Name

Orbital Therapeutics Inc.

Operating Status

Active

Company Type

For Profit

Founders

Carol Suh, Drew Weissman, Gene Yeo, Giuseppe Ciaramella, Howard Chang, John Maraganore, Kristina Burow, Ravi Majeti

About the Company

Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines to treat human disease in ways that were not previously possible. To produce an extended portfolio of medications, the company is developing an innovative platform at the confluence of RNA technology, delivery techniques, data analytics, and

automation.

Contact Email

info@orbitaltx.com

Diversity Spotlight

Women Founded

Predictions & Insights

Growth Insight

See this Growth Insight

Orbital Therapeutics is

Lorem

to be growing

Top Contributing Factors

Merger or Acquisition

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

RNA Medicines Platform

A technology-agnostic platform for designing RNA-based therapeutics tailored to specific disease biology, optimizing expression, duration, and tissue targeting.

Immunomodulation RNA Therapeutics

RNA-based treatments designed to modulate the immune system for autoimmune diseases and oncology by in vivo expression of CARs and immunomodulatory proteins.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Orbital Therapeutics	14	obfuscated obfuscation	ARCH Venture Partners	Series A
obfuscated obfuscation	Series A - Orbital Therapeutics	14	obfuscated obfuscation	ARCH Venture Partners	Series A
obfuscated obfuscation	Series A - Orbital Therapeutics	14	obfuscated obfuscation	ARCH Venture Partners	Series A
obfuscated obfuscation	Series A - Orbital Therapeutics	14	obfuscated obfuscation	ARCH Venture Partners	Series A
obfuscated obfuscation	Series A - Orbital Therapeutics	14	obfuscated obfuscation	ARCH Venture Partners	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Orbital Therapeutics	14	obfuscated obfuscation	ARCH Venture Partners	Series A
obfuscated obfuscation	Series A - Orbital Therapeutics	14	obfuscated obfuscation	ARCH Venture Partners	Series A
obfuscated obfuscation	Series A - Orbital Therapeutics	14	obfuscated obfuscation	ARCH Venture Partners	Series A
obfuscated obfuscation	Series A - Orbital Therapeutics	14	obfuscated obfuscation	ARCH Venture Partners	Series A
obfuscated obfuscation	Series A - Orbital Therapeutics	14	obfuscated obfuscation	ARCH Venture Partners	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Andreessen Horowitz	—	Series A - Orbital Therapeutics	Vineeta Agarwala
Andreessen Horowitz	—	Series A - Orbital Therapeutics	Vineeta Agarwala
Andreessen Horowitz	—	Series A - Orbital Therapeutics	Vineeta Agarwala
Andreessen Horowitz	—	Series A - Orbital Therapeutics	Vineeta Agarwala
Andreessen Horowitz	—	Series A - Orbital Therapeutics	Vineeta Agarwala